...
首页> 外文期刊>Oncogene >Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p
【24h】

Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p

机译:3号染色体片段的转移抑制了3p号染色体的卵巢癌细胞系等位基因的致癌性

获取原文
           

摘要

Multiple chromosome 3p tumor suppressor genes (TSG) have been proposed in the pathogenesis of ovarian cancer based on complex patterns of 3p loss. To attain functional evidence in support of TSGs and identify candidate regions, we applied a chromosome transfer method involving cell fusions of the tumorigenic OV90 human ovarian cancer cell line, monoallelic for 3p and an irradiated mouse cell line containing a human chromosome 3 in order to derive OV90 hybrids containing normal 3p fragments. The resulting hybrids showed complete or incomplete suppression of tumorigenicity in nude mouse xenograft assays, and varied in their ability to form colonies in soft agarose and three-dimensional spheroids in a manner consistent with alteration of their in vivo tumorigenic phenotypes. Expression microarray analysis identified a set of common differentially expressed genes, such as SPARC, DAB2 and VEGF, some of which have been shown implicated in ovarian cancer. Genotyping assays revealed that they harbored normal 3p fragments, some of which overlapped candidate TSG regions (3p25–p26, 3p24 and 3p14-pcen) identified previously in loss of heterozygosity analyses of ovarian cancers. However, only the 3p12-pcen region was acquired in common by all hybrids where expression microarray analysis identified differentially expressed genes. The correlation of 3p12-pcen transfer and tumor suppression with a concerted re-programming of the cellular transcriptome suggest that the putative TSG may have affected key underlying events in ovarian cancer.
机译:基于3p丢失的复杂模式,已经在卵巢癌的发病机理中提出了多染色体3p抑癌基因(TSG)。为了获得支持TSGs的功能证据并确定候选区域,我们应用了一种染色体转移方法,该方法涉及致瘤性OV90人卵巢癌细胞系,3p单等位基因和包含人3号染色体的经辐照的小鼠细胞系的细胞融合。包含正常3p片段的OV90杂种。所得杂种在裸鼠异种移植测定中显示出完全或不完全抑制致瘤性,并且以与改变其体内致瘤表型一致的方式改变了在软琼脂糖和三维球体中形成菌落的能力。表达微阵列分析鉴定出一组常见的差异表达基因,例如SPARC,DAB2和VEGF,其中一些已显示与卵巢癌有关。基因分型分析显示,它们具有正常的3p片段,其中一些重叠了先前在卵巢癌杂合性丧失分析中鉴定出的候选TSG区域(3p25–p26、3p24和3p14–pcen)。但是,所有3p12-pcen区都是所有杂种共同获得的,在这些杂种中,表达微阵列分析可鉴定出差异表达的基因。 3p12-pcen转移和肿瘤抑制与细胞转录组协同重新编程的相关性表明,推定的TSG可能已经影响了卵巢癌的关键潜在事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号